Didier Scherrer
Chief Tech/Sci/R&D Officer at ABIVAX
Net worth: 564 574 $ as of 2024-04-29
Didier Scherrer active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ABIVAX | Chief Tech/Sci/R&D Officer | - | - |
Career history of Didier Scherrer
Former positions of Didier Scherrer
| Companies | Position | Start | End |
|---|---|---|---|
LFB Biotechnologies SASU
 LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Chief Tech/Sci/R&D Officer | 2008-05-31 | 2009-08-31 |
AstraZeneca SAS
 AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Corporate Officer/Principal | 2005-09-30 | 2008-05-31 |
Entelos, Inc.
 Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Chief Tech/Sci/R&D Officer | 2000-08-31 | 2005-08-31 |
Splicos SAS
 Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Chief Executive Officer | 2009-08-31 | - |
Training of Didier Scherrer
| Harvard Medical School | Doctorate Degree |
| Stanford University School of Medicine | Doctorate Degree |
| Louis Pasteur University | Doctorate Degree |
Statistics
International
| France | 6 |
| United States | 4 |
Operational
| Doctorate Degree | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 1 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| ABIVAX | Health Technology |
| Private companies | 4 |
|---|---|
Splicos SAS
Splicos SAS Miscellaneous Commercial ServicesCommercial Services Splicos SAS provides therapeutic research and development services. The firm specializes in generating therapeutic leads and drug candidates for cancer, HIV, and genetic diseases. It offers technologies in the fields of alternative splicing and metastatic migration. The company was founded in 2008 and is headquartered in Montpellier, France. | Commercial Services |
Entelos, Inc.
Entelos, Inc. Information Technology ServicesTechnology Services Entelos, Inc. develops predictive computer models of human disease. Its solutions include mechanism-based, mathematical models; virtual patients, populations; biosimulation software and biosimulation expertise. The company was founded in 1996 and is headquartered in San Mateo, CA. | Technology Services |
AstraZeneca SAS
AstraZeneca SAS Pharmaceuticals: MajorHealth Technology AstraZeneca SAS researches, develops, produces, and commercializes pharmaceutical products. It offers solutions in different domains such as cardio-vascular, metabolism, oncology, respiratory, and inflammatory diseases. The company was founded on April 21, 1955 and is headquartered in Courbevoie, France. | Health Technology |
LFB Biotechnologies SASU
LFB Biotechnologies SASU BiotechnologyHealth Technology LFB Biotechnologies SASU provides plasma-derived medicinal products. The firm undertakes research and development programs in plasma fractions and biotechnologies in the areas of autoimmune diseases and hemostasis disorders. The company was founded on September 21, 2006 and is headquartered in Courtaboeuf, France. | Health Technology |
- Stock Market
- Insiders
- Didier Scherrer
- Experience
